139 related articles for article (PubMed ID: 2734342)
1. Physostigmine-insensitive behavioral excitatory effects of atropine in squirrel monkeys.
Witkin JM; Markowitz RA; Barrett JE
Pharmacol Biochem Behav; 1989 Jan; 32(1):309-15. PubMed ID: 2734342
[TBL] [Abstract][Full Text] [Related]
2. Central and peripheral muscarinic actions of physostigmine and oxotremorine on avoidance responding of squirrel monkeys.
Witkin JM
Psychopharmacology (Berl); 1989; 97(3):376-82. PubMed ID: 2497488
[TBL] [Abstract][Full Text] [Related]
3. Effects of phencyclidine, atropine and physostigmine, alone and in combination, on variable-interval performance in the squirrel monkey.
Chait LD; Balster RL
Pharmacol Biochem Behav; 1979 Jul; 11(1):37-42. PubMed ID: 115014
[TBL] [Abstract][Full Text] [Related]
4. Alterations in the effects of atropine on the behavior of pigeons following chronic administration.
Schaal DW; Branch MN
Pharmacol Biochem Behav; 1987 Nov; 28(3):375-80. PubMed ID: 3685073
[TBL] [Abstract][Full Text] [Related]
5. Effects of selective central muscarinic blockade on schedule-controlled behavior and on the rate-decreasing effects of physostigmine.
Hymowitz N; Brezenoff HE
Pharmacol Biochem Behav; 1984 Jul; 21(1):109-15. PubMed ID: 6463084
[TBL] [Abstract][Full Text] [Related]
6. Effects of physostigmine, atropine and scopolamine on behavior maintained by a multiple schedule of food presentation in the mouse.
Wenger GR
J Pharmacol Exp Ther; 1979 Apr; 209(1):137-43. PubMed ID: 430373
[No Abstract] [Full Text] [Related]
7. Effects of azaprophen, scopolamine and trihexyphenidyl on schedule-controlled behavior, before and after chronic physostigmine.
Genovese RF
Eur J Pharmacol; 1990 Feb; 176(3):271-9. PubMed ID: 2328755
[TBL] [Abstract][Full Text] [Related]
8. Relationship of the behavioral effects of aprophen, atropine and scopolamine to antagonism of the behavioral effects of physostigmine.
Genovese RF; Elsmore TF; Witkin JM
Pharmacol Biochem Behav; 1990 Sep; 37(1):117-22. PubMed ID: 2263653
[TBL] [Abstract][Full Text] [Related]
9. Modification of behavioral effects of morphine, meperidine and normeperidine by naloxone and by morphine tolerance.
Witkin JM; Leander JD; Dykstra LA
J Pharmacol Exp Ther; 1983 May; 225(2):275-83. PubMed ID: 6842391
[TBL] [Abstract][Full Text] [Related]
10. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
Shannon HE; Bemis KG; Hendrix JC; Ward JS
J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of oxotremorine-induced behavioral suppression by antimuscarinic drugs.
Leander JD
Psychopharmacology (Berl); 1981; 75(1):5-8. PubMed ID: 6795660
[TBL] [Abstract][Full Text] [Related]
12. Effects of LY150720 (picenadol), a novel mixed-action opioid, on schedule-controlled responding in the squirrel monkey.
Carter RB; Dykstra LA
Pharmacol Biochem Behav; 1984 Nov; 21(5):779-86. PubMed ID: 6514768
[TBL] [Abstract][Full Text] [Related]
13. Behavioral effects of some diphenyl-substituted antimuscarinics: comparison with cocaine and atropine.
Witkin JM; Genovese RF; Witkin KM; Chiang PK
Pharmacol Biochem Behav; 1992 Feb; 41(2):377-84. PubMed ID: 1574528
[TBL] [Abstract][Full Text] [Related]
14. Scopolamine self-administration: cholinergic involvement in reward mechanisms.
Glick SD; Guido RA
Life Sci; 1982 Aug; 31(9):909-13. PubMed ID: 7176819
[TBL] [Abstract][Full Text] [Related]
15. Memory facilitation with posttrial injection of oxotremorine and physostigmine in mice.
Baratti CM; Huygens P; Miño J; Merlo A; Gardella J
Psychopharmacology (Berl); 1979 Jun; 64(1):85-8. PubMed ID: 113837
[TBL] [Abstract][Full Text] [Related]
16. Discriminative stimulus properties of physostigmine in rats.
Tang AH; Franklin SR
Eur J Pharmacol; 1988 Aug; 153(1):97-104. PubMed ID: 3215280
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects elicited by central administration of physostigmine via M2 muscarinic receptors in conscious cats.
Ally A; Wilson LB; Nóbrega AC; Mitchell JH
Brain Res; 1995 Apr; 677(2):268-76. PubMed ID: 7552252
[TBL] [Abstract][Full Text] [Related]
18. Centrally active antimuscarinic analogs of oxotremorine selectively block physostigmine-induced hypertension, but not peripheral muscarinic vasodepression.
Vargas HM; Ringdahl B
J Pharmacol Exp Ther; 1990 Apr; 253(1):165-70. PubMed ID: 2329503
[TBL] [Abstract][Full Text] [Related]
19. Tolerance to behavioral effects of physostigmine under interval schedules of positive or negative reinforcement.
Galbicka G; Elsmore TF; Witkin JM
Psychopharmacology (Berl); 1989; 97(4):448-55. PubMed ID: 2498941
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological evidence for nicotinic and muscarinic modulation of spinal cord reflexes.
Ibrahim NA; Goldstein BD
Neuropharmacology; 1989 Sep; 28(9):977-83. PubMed ID: 2812287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
